P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling

Published:2018-01-17 Issue:1 Volume:11 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

de Almeida Chuffa Luiz Gustavo,de Moura Ferreira Grazielle,Lupi Luiz Antonio,da Silva Nunes Iseu,Fávaro Wagner José

Funder

FAPESP

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-018-0380-5.pdf

Reference40 articles.

1. Cannistra SA. Cancer of the ovary. New Engl J Med 2004; 351: 2519–2565.

2. Fallows S, Price J, Atkinson RJ, Johnston PG, Hickey I, Russell SE. P53 mutation does not affect prognosis in ovarian epithelial malignancies. J Pathol. 2001;194:68–75.

3. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006;66:3859–68.

4. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G. Cancers take their toll–the function and regulation of toll-like receptors in cancer cells. Oncogene. 2008;27:225–33.

5. Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, Nowak-Markwitz E, et al. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene. 2009;28:4353–63.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer;BMC Women's Health;2024-08-30

2. TLR AND CANCER: THE ENIGMATIC CROSS TALK;Thirty Years since the Discovery of Toll-Like Receptors;2024-03-20

3. A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad® immunotherapy associated with platelet-rich plasma;International Immunopharmacology;2023-10

4. The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer;Frontiers in Pharmacology;2022-12-16

5. Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment;Journal of Clinical Investigation;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3